Semaglutide 10mg

$72.00

RESEARCH USE ONLY

10 in stock (can be backordered)

1 Vial
$55.00 Per Vial
$55.00
2 Vials
$52.25 Per Vial (SAVE 5% Per Vial)
$104.50
$110.00
3 Vials
$49.50 Per Vial (SAVE 10% Per Vial)
$148.50
$165.00
4 Vials
$46.75 Per Vial (SAVE 15% Per Vial)
$187.00
$220.00
5 Vials
$44.00 Per Vial (SAVE 20% Per Vial)
$220.00
$275.00
6 Vials
$41.25 Per Vial (SAVE 25% Per Vial)
$247.50
$330.00
7 Vials
$38.50 Per Vial (SAVE 30% Per Vial)
$269.50
$385.00
8 Vials
$35.75 Per Vial (SAVE 35% Per Vial)
$286.00
$440.00
9 Vials
$33.00 Per Vial (SAVE 40% Per Vial)
$297.00
$495.00
10 Vials
$30.25 Per Vial (SAVE 45% Per Vial)
$302.50
$550.00
Category:

Description

Semaglutide is a long-acting synthetic GLP-1 peptide analogue that has become one of the most extensively researched peptides for appetite regulation, glucose metabolism, and body-weight management.

Its selective GLP-1 receptor activity affects appetite signaling, insulin secretion, glucagon regulation, and gastric emptying, creating a broad metabolic effect from a single peptide pathway.

Product Information
Semaglutide is structurally related to endogenous GLP-1 but has been modified to remain active for considerably longer.

Rather than supplying growth hormones or metabolic substrates directly, semaglutide activates GLP-1 receptors involved in appetite, glucose regulation, and gastrointestinal function.

How Does Semaglutide Work?
Semaglutide activates GLP-1 receptors, increasing glucose-dependent insulin secretion while influencing appetite and gastric emptying. These effects can reduce energy intake and improve glucose regulation.

Semaglutide Benefits
Helps Regulate Appetite
Semaglutide directly interacts with GLP-1 pathways involved in hunger and satiety. Clinical research has shown that this signaling can substantially reduce energy intake, making appetite control one of its defining characteristics.

Produces Significant Weight Reduction
The STEP-1 trial evaluated once-weekly semaglutide at 2.4 mg for 68 weeks. Mean body weight decreased by 14.9% with semaglutide compared with 2.4% with placebo.

Supports Glucose Regulation
GLP-1 receptor activation improves glucose-dependent insulin secretion and helps regulate glucagon responses. This makes semaglutide an important research peptide for studying glucose homeostasis and metabolic dysfunction.

Influences Multiple Metabolic Pathways
Semaglutide’s effects extend beyond appetite alone. Research has examined its influence on body composition, waist circumference, glycemic control, and broader cardiovascular risk factors, making it one of the best-characterized GLP-1 peptides.